FarmaKeio Custom Compounding Expands Services with Acquisition of Advanced Facility in Conway, Arkansas

FarmaKeio Custom Compounding

CONWAY, Ark., October 20, 2023 (VSNewsNetwork.com) - FarmaKeio Custom Compounding, a pharmaceutical company specializing in custom compounded medications, has acquired a new facility in Conway, Arkansas, as part of its ongoing national expansion. The $2.29 million investment aims to bolster the company's mission of delivering personalized healthcare solutions to patients and healthcare providers across the United States. The expansion is projected to create 74 new jobs in Conway.

"Today marks a momentous occasion for FarmaKeio as we proudly inaugurate our new Custom Compounding facility in Conway," said Dan DeNeui, CEO of FarmaKeio. The 16,000-square-foot facility is equipped with state-of-the-art compounding and laboratory equipment, as well as office space, production areas, and a warehouse. Governor Sarah Huckabee Sanders expressed her administration's support, stating, “In my administration, we’re doing everything we can to make announcements like this regular by cutting taxes, investing in education, and building up a robust workforce.” Clint O’Neal, executive director of the Arkansas Economic Development Commission, added, “FarmaKeio Custom Compounding is a fast-growing company, and the State of Arkansas is proud to be the home for their next location.”

The Conway location will focus on compounded hormone medications and peptide medications tailored to individual patient needs. FarmaKeio Pharmacy Network has future plans to develop a second location for FarmaKeio Outsourcing, an FDA-registered facility known for its patented pellet formulated with triamcinolone. Conway Mayor Bart Castleberry remarked, “We thank FarmaKeio Custom Compounding for choosing Conway and for adding to the diverse array of job opportunities for our people.”

For more information on FarmaKeio Custom Compounding, visit www.fko-outsourcing.com.

Source: FarmaKeio Pharmacy Network via Newswire